Hikma Pharmaceuticals PLC (HKMPF)
24.50
0.00 (0.00%)
USD |
OTCM |
May 06, 16:00
Hikma Pharmaceuticals 1 Year Total Returns (Daily): 10.24% for May 6, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 06, 2024 | 10.24% |
| May 03, 2024 | 10.24% |
| May 02, 2024 | 0.47% |
| May 01, 2024 | -0.76% |
| April 30, 2024 | -0.76% |
| April 29, 2024 | -0.76% |
| April 26, 2024 | 11.42% |
| April 25, 2024 | 11.42% |
| April 24, 2024 | 11.42% |
| April 23, 2024 | 11.42% |
| April 22, 2024 | 11.42% |
| April 19, 2024 | 11.42% |
| April 18, 2024 | 11.42% |
| April 17, 2024 | 11.42% |
| April 16, 2024 | 21.00% |
| April 15, 2024 | 21.00% |
| April 12, 2024 | 21.00% |
| April 11, 2024 | 21.00% |
| April 10, 2024 | 21.00% |
| April 09, 2024 | 21.00% |
| April 08, 2024 | 21.00% |
| April 05, 2024 | 21.00% |
| April 04, 2024 | 21.00% |
| April 03, 2024 | 21.00% |
| April 02, 2024 | 21.00% |
| Date | Value |
|---|---|
| April 01, 2024 | 21.00% |
| March 28, 2024 | 16.61% |
| March 27, 2024 | 16.61% |
| March 26, 2024 | 16.61% |
| March 25, 2024 | 16.61% |
| March 22, 2024 | 18.66% |
| March 21, 2024 | 18.66% |
| March 20, 2024 | 16.32% |
| March 19, 2024 | 16.32% |
| March 18, 2024 | 16.32% |
| March 15, 2024 | 16.32% |
| March 14, 2024 | 16.32% |
| March 13, 2024 | 16.32% |
| March 12, 2024 | 16.32% |
| March 11, 2024 | 16.32% |
| March 08, 2024 | 16.32% |
| March 07, 2024 | 16.32% |
| March 06, 2024 | 19.95% |
| March 05, 2024 | 21.04% |
| March 04, 2024 | 21.04% |
| March 01, 2024 | 21.04% |
| February 29, 2024 | 18.24% |
| February 28, 2024 | 28.84% |
| February 27, 2024 | 28.84% |
| February 26, 2024 | 28.84% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-58.83%
Minimum
Sep 23 2022
101.6%
Maximum
Sep 25 2023
10.53%
Average
15.04%
Median
Jan 28 2020
1 Year Total Returns (Daily) Benchmarks
| Adaptimmune Therapeutics PLC | -19.29% |
| Biodexa Pharmaceuticals Plc | -93.54% |
| Verona Pharma PLC | -30.98% |
| NuCana PLC | -78.00% |
| Autolus Therapeutics PLC | 115.3% |